All In Biotech

Drug Trial Radar · NCT02601703

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Tacrolimus Ointment, 0.1% (Glenmark Pharmaceuticals, Ltd) to the Marketed Product Protopic® (Tacrolimus) Ointment, 0.1% (Astellas Pharma US, Inc.) in the Treatment of Moderate to Severe Atopic Dermatitis (AD)

Last checked: Nov 19, 2026Latest source record: Jul 31, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,110 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,110

Actual

Start

Aug 2015

Primary completion

Oct 2016

Study completion Oct 2016

Sponsor

Sponsor type
Industry
First posted
Nov 10, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Tacrolimus Ointment, 0.1% (Glenmark Pharmaceuticals, Ltd) to the Marketed Product Protopic® (tacrolimus) ointment, 0.1% (Astellas Pharma US, Inc.) in the Treatment of Moderate to Severe Atopic Dermatitis (AD).

Conditions

  • Atopic Dermatitis

Interventions

  • Tacrolimus Ointment 0.1%Drug

    apply thin layer of ointment to affected area

  • Protopic® ointment, 0.1%Drug

    apply thin layer of ointment to affected area

  • Placebo of Tacrolimus OintmentDrug

    apply thin layer of ointment to affected area

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigator's Global Assessment (IGA) score of 0 or 1 within all treatment areas at the end of treatmentTime frame: Day 15

Locations

60 sites in 1 country. Site status is shown where the registry gives one.

  • Glenmark Investigational Site 49

    Tempe, Arizona

  • Glenmark Investigational Site 31

    Anaheim, California

  • Glenmark Investigational Site 23

    Bell Gardens, California

  • Glenmark Investigational Site 30

    Cerritos, California

  • Glenmark Investigational Site 15

    Chula Vista, California

  • Glenmark Investigational Site 14

    La Mesa, California

  • Glenmark Investigational Site 1

    Long Beach, California

  • Glenmark Investigational Site 17

    Oceanside, California

  • Glenmark Investigational Site 25

    Pasadena, California

  • Glenmark Investigational Site 20

    San Ramon, California

  • Glenmark Investigational Site 44

    Santa Ana, California

  • Glenmark Investigational Site 45

    Brooksville, Florida

  • Glenmark Investigational Site 43

    Coral Gables, Florida

  • Glenmark Investigational Site 34

    Doral, Florida

  • Glenmark Investigational Site 22

    Fort Lauderdale, Florida

  • Glenmark Investigational Site 35

    Hialeah, Florida

  • Glenmark Investigational Site 59

    Hialeah Gardens, Florida

  • Glenmark Investigational Site 11

    Miami, Florida

  • Glenmark Investigational Site 19

    Miami, Florida

  • Glenmark Investigational Site 33

    Miami, Florida

  • Glenmark Investigational Site 40

    Miami, Florida

  • Glenmark Investigational Site 42

    Miami, Florida

  • Glenmark Investigational Site 50

    Miami, Florida

  • Glenmark Investigational Site 51

    Miami, Florida

  • Glenmark Investigational Site 54

    Miami, Florida

  • Glenmark Investigational Site 56

    Miami, Florida

  • Glenmark Investigational Site 58

    Miami, Florida

  • Glenmark Investigational Site7

    Miami, Florida

  • Glenmark Investigational Site 28

    Miami Gardens, Florida

  • Glenmark Investigational Site 29

    Miami Lakes, Florida

  • Glenmark Investigational Site 18

    Miramar, Florida

  • Glenmark Investigational Site 32

    North Miami Beach, Florida

  • Glenmark Investigational Site 48

    Orlando, Florida

  • Glenmark Investigational Site 4

    Ormond Beach, Florida

  • Glenmark Investigational Site 47

    Pembroke Pines, Florida

  • Glenmark Investigational Site 5

    Winter Park, Florida

  • Glenmark Investigational Site 52

    Macon, Georgia

  • Glenmark Investigational Site12

    Madisonville, Kentucky

  • Glenmark Investigational Site 2

    Saint Joseph, Missouri

  • Glenmark Investigational Site 41

    Henderson, Nevada

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.